000 01240 a2200361 4500
005 20250517200416.0
264 0 _c20181115
008 201811s 0 0 chi d
022 _a1009-2137
024 7 _a10.7534/j.issn.1009-2137.2018.01.027
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDeng, Yu-Jie
245 0 0 _a[Significance of H3K27me3 and EZH2 in Predicting the Therapeutic Efficacy of Diffuse Large B-Cell Lymphoma].
_h[electronic resource]
260 _bZhongguo shi yan xue ye xue za zhi
_cFeb 2018
300 _a159-165 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aEnhancer of Zeste Homolog 2 Protein
650 0 4 _aHistones
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aLymphoma, Large B-Cell, Diffuse
650 0 4 _aPrognosis
650 0 4 _aRemission Induction
700 1 _aChen, Gang
700 1 _aZhu, Wei-Feng
700 1 _aChen, Xiao-Hui
700 1 _aHong, Hua-Lan
700 1 _aHuang, Li-Ming
700 1 _aShi, Xi
700 1 _aChen, Jun-Min
773 0 _tZhongguo shi yan xue ye xue za zhi
_gvol. 26
_gno. 1
_gp. 159-165
856 4 0 _uhttps://doi.org/10.7534/j.issn.1009-2137.2018.01.027
_zAvailable from publisher's website
999 _c28041421
_d28041421